l-carnitine tmao nature medicine 2013 koeth TMAO: how gut microbiota contributes to heart failure γ–Butyrobetaine is a pro-atherogenic intermediate
Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC Dietary allicin reduces transformation of L carnitine to TMAO through impact on gut microbiota ScienceDirect Gut microbiota derived metabolites in cardiovascular health and disease Protein & Cell Springer Nature Link Trimethylamine Trimethylamine N Oxide as a Key Between Diet and Cardiovascular Diseases Cardiovascular Toxicology Springer Nature Link The microbial metabolite trimethylamine N oxide promotes antitumor immunity in triple negative breast cancer: Cell Metabolism Frontiers Gut Metabolite Trimethylamine N Oxide in Atherosclerosis: From Mechanism to Therapy
Pay in 4 interest-free payments of $5.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 20 - Sep 25





